Clinical Trial Update: Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Yangxinshi Tablet for exercise capacity in patients with chronic coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Yangxinshi Tablet

Snippet

Sponsor: Shandong First Medical University | Conditions: Chronic Coronary Syndrome | Phase 4 | Status: RECRUITING